Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q15047 (SETB1_HUMAN) Homo sapiens (Human)

Histone-lysine N-methyltransferase SETDB1 UniProtKBInterProSTRINGInteractive Modelling

1291 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of SETDB1 with a modified H3 peptide Heteromer
P68431;
190-406
35×UNX;NA;
Assess
Crystal structure of SETDB1 with a modified H3 peptide Heteromer
P68431;
190-406
36×UNX;
Assess
Crystal structure of SETDB1 with a modified H3 peptide Heteromer
P68431;
190-406
35×UNX;
Assess
Crystal structure of SETDB1 with a modified H3 peptide Heteromer
P68431;
190-406
40×UNX;
Assess
Crystal structure of SETDB1 with a modified H3 peptide Heteromer
P68431;
190-402
SO4; 26×UNX;
Assess
Crystal structure of chromobox homology 7 (CBX7) with SETDB1-1170me3 Peptide Heteromer
Q8VDS3;
1165-1173
FE;CIT;
Assess
Complex of SETDB1-derived peptide bound to UBE2E1 Heteromer
P51965;
867-872
SO4;
Assess
Crystal Structure of SETDB1 tudor domain in complexed with Compound 6homo-2-mer191-405
FVR;CIT;
Assess
Crystal structure of SETDB1 tudor domain in complexed with Compound 1.homo-2-mer190-403
FN9;
Assess
Crystal structure of SETDB1 Tudor domain in complexed with Compound 2.homo-2-mer192-402
FNC;
Assess
Crystal Structure of SETDB1 Tudor domain in complexed with (R,R)-59monomer192-403
G09;
Assess
SETDB1 in complex with an early stage, low affinity fragment candidate modelled at reduced occupancymonomer196-401
SO4;6RO; 47×UNX;DMS;
Assess
SETDB1 in complex with an early stage, low affinity fragment candidate modelled at reduced occupanc…monomer196-401
50×UNX;DMS;SO4;6RN;
Assess
Crystal structure of SETDB1 Tudor domain in complex with MR46747monomer196-401
XRU;SO4;EDO;UNX;
Assess
Crystal structure of SETDB1 Tudor domain in complex with inhibitor XST06472Amonomer196-400
6S4;EDO;SO4;UNX;
Assess
Crystal structure of SETDB1 Tudor domain with aryl triazole fragmentsmonomer196-400
CGJ;BME;SO4;EDO; 13×UNX;
Assess
Crystal Structure of SETDB1 Tudor domain in complex with UNC6535monomer196-400
YOH;UNX;
Assess
SETDB1 in complex with a fragment candidatemonomer196-400
EDO;DMS;SO4;CL;6SU;PEG;ACT;GOL;
Assess
Crystal structure of SETDB1 Tudor domain with aryl triazole fragment peptide conjugatesmonomer196-399
SO4;EDO;UNX;
Assess
Crystal structure of SETDB1 Tudor domain in complex with fragment MRT0181amonomer196-399
6S5;BME;SO4; 10×UNX;
Assess
Crystal structure of SETDB1 Tudor domain with aryl triazole fragmentsmonomer196-399
BWM;SO4;EDO;UNX;
Assess
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in…monomer196-397
DMS;EDO;DSJ; 38×UNX;SO4;
Assess
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in…monomer196-397
DMS;EDO;AW7; 36×UNX;SO4;
Assess
Crystal structure of Tudor domain of human Histone-lysine N-methyltransferase SETDB1monomer196-397
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7c9n.1.Ahomo-2-mer0.83190-403
FN9;100.00
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26bhd.1.Amonomer0.83190-381
99.48
Assess
Isoform 24ad8.1.Amonomer0.6533-107
18.67
Assess
Isoform 28swj.3.Amonomer0.59196-320
19.47
Assess
Isoform 37c9n.1.Ahomo-2-mer0.82190-403
FN9;100.00
Assess